MENU
DAWN
AS OF
Feb 3 closing price
Price
$11.16
Change
+$3.72 (+50.00%)
Capitalization
1.14B
33 days until earnings call
Intraday BUY SELL Signals
+Compare
DAWN
Stock ticker: NASDAQ
AS OF
Feb 3 closing price
Price
$11.16
Change
+$3.72 (+50.00%)
Capitalization
1.14B

DAWN Day One Biopharmaceuticals Forecast, Technical & Fundamental Analysis

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company... Show more

DAWN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for DAWN with price predictions
Feb 03, 2026

DAWN in upward trend: price rose above 50-day moving average on January 07, 2026

DAWN moved above its 50-day moving average on January 07, 2026 date and that indicates a change from a downward trend to an upward trend. In of 48 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DAWN advanced for three days, in of 278 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 134 cases where DAWN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for DAWN moved out of overbought territory on January 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 20 similar instances where the indicator moved out of overbought territory. In of the 20 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 49 cases where DAWN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on February 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DAWN as a result. In of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for DAWN turned negative on January 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DAWN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

DAWN broke above its upper Bollinger Band on January 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DAWN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.539) is normal, around the industry mean (27.519). P/E Ratio (0.000) is within average values for comparable stocks, (51.491). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.893). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (8.584) is also within normal values, averaging (331.843).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DAWN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
DAWN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

DAWN is expected to report earnings to rise 1.58% to -19 cents per share on March 09

Day One Biopharmaceuticals DAWN Stock Earnings Reports
Q4'25
Est.
$-0.19
Q3'25
Beat
by $0.10
Q2'25
Beat
by $0.06
Q1'25
Beat
by $0.07
Q4'24
Missed
by $0.17
The last earnings report on November 04 showed earnings per share of -18 cents, beating the estimate of -28 cents. With 1.90M shares outstanding, the current market capitalization sits at 1.14B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2000 Sierra Point Parkway
Phone
+1 650 484-0899
Employees
155
Web
https://www.dayonebio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IRFAX9.500.10
+1.06%
Cohen & Steers International Realty A
TSRMX18.130.07
+0.39%
Touchstone Sands Cptl Emerg Mkts Gr R6
FBSIX39.050.01
+0.03%
Franklin Mutual U.S. Mid Cap Value R6
FFIDX114.07N/A
N/A
Fidelity
WCPIX59.33-1.47
-2.42%
Communication Services UltraSectorProInv

DAWN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, DAWN has been loosely correlated with OCUL. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if DAWN jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DAWN
1D Price
Change %
DAWN100%
+3.05%
OCUL - DAWN
48%
Loosely correlated
+0.11%
IMTX - DAWN
46%
Loosely correlated
+4.61%
NUVL - DAWN
45%
Loosely correlated
+2.00%
BEAM - DAWN
44%
Loosely correlated
+1.09%
ERAS - DAWN
44%
Loosely correlated
+0.95%
More